Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaneka Corporation is a diversified Japanese chemical company with significant operations in life sciences. Through its subsidiaries like Kaneka Eurogentec S.A. and partnerships/acquisitions such as AB-BIOTICS, it provides CDMO services for plasmid DNA, recombinant proteins, oligonucleotides and mRNA therapeutics/vaccines. It also develops medical devices and nutritional supplements including probiotics. The company has expanded its GMP manufacturing capacity to meet global demand for advanced biologics including mRNA-based drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaneka.